
XFOR Valuation
X4 Pharmaceuticals Inc
- Overview
- Forecast
- Valuation
- Earnings
XFOR Relative Valuation
XFOR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, XFOR is overvalued; if below, it's undervalued.
Historical Valuation
X4 Pharmaceuticals Inc (XFOR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.33 is considered Undervalued compared with the five-year average of -2.02. The fair price of X4 Pharmaceuticals Inc (XFOR) is between 4.49 to 7.33 according to relative valuation methord. Compared to the current price of 1.49 USD , X4 Pharmaceuticals Inc is Undervalued By 66.79%.
Relative Value
Fair Zone
4.49-7.33
Current Price:1.49
66.79%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
1.04
P/B
Median3y
17.30
Median5y
10.74
-441.68
FCF Yield
Median3y
-108.15
Median5y
-96.80
Competitors Valuation Multiple
The average P/S ratio for XFOR's competitors is 19.56, providing a benchmark for relative valuation. X4 Pharmaceuticals Inc Corp (XFOR) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

IMUX
Immunic Inc
0.936
USD
+0.54%

VMCA
Valuence Merger Corp I
11.740
USD
-0.17%

ELVA
Electrovaya Inc
3.820
USD
+1.60%

OSS
One Stop Systems Inc
5.410
USD
-3.91%

AZI
Autozi Internet Technology (Global) Ltd
0.261
USD
-2.98%

IMAB
I-Mab
2.080
USD
-1.89%

DBVT
Dbv Technologies SA
9.280
USD
-2.36%

VOC
VOC Energy Trust
3.130
USD
+3.30%

ENTX
Entera Bio Ltd
1.950
USD
-1.96%

MVO
MV Oil Trust
6.030
USD
+2.20%
FAQ

Is X4 Pharmaceuticals Inc (XFOR) currently overvalued or undervalued?
X4 Pharmaceuticals Inc (XFOR) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.33 is considered Undervalued compared with the five-year average of -2.02. The fair price of X4 Pharmaceuticals Inc (XFOR) is between 4.49 to 7.33 according to relative valuation methord. Compared to the current price of 1.49 USD , X4 Pharmaceuticals Inc is Undervalued By 66.79% .

What is X4 Pharmaceuticals Inc (XFOR) fair value?

How does XFOR's valuation metrics compare to the industry average?

What is the current P/B ratio for X4 Pharmaceuticals Inc (XFOR) as of Jul 22 2025?

What is the current FCF Yield for X4 Pharmaceuticals Inc (XFOR) as of Jul 22 2025?

What is the current Forward P/E ratio for X4 Pharmaceuticals Inc (XFOR) as of Jul 22 2025?
